GlassScriptPhysician profile
Jenelle C Wong
NPI 1396844270
$1,541.55
in general payments reported to CMS, 2019-2025
15 companies · $210 in 2025
The $210 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $76.76 · 2021: $444 · 2022: $76.58 · 2023: $109 · 2024: $147 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $335.60 | 2021-2024 | Qelbree |
| Glaxosmithkline, LLC. | $270.02 | 2020-2025 | Penmenvy, Bexsero |
| Genentech USA, INC. | $266.47 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $239.24 | 2019 | |
| Corium, LLC | $76.21 | 2022-2025 | Azstarys |
| Pfizer INC. | $64.31 | 2019-2024 | |
| Cranial Technologies, INC | $63.95 | 2019-2021 | |
| Alk-Abello, INC | $60.81 | 2023 | Ragwitek, Odactra, Grastek |
| Sanofi Pasteur INC. | $44.18 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $31.32 | 2021-2025 | Vaxneuvance, Rotateq, Gardasil 9 |
| Tris Pharma INC | $28.46 | 2019-2020 | |
| Shire North American Group INC | $18.12 | 2019 | |
| Kaleo, INC. | $16.50 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.48 | 2020 | |
| Neos Therapeutics, LP | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenelle Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.